This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Mixed Oligodendroglioma-astrocytoma
Information about Mixed Oligodendroglioma-astrocytoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Mixed Oligodendroglioma-astrocytoma
Most recent studies have shown that Mixed Oligodendroglioma-astrocytoma shares some biological mechanisms with anaplastic-astrocytoma, anaplastic-oligoastrocytoma, anaplastic-oligodendroglioma, astrocytoma, brain-neoplasms, ependymoma, glioblastoma, glioblastoma-multiforme, glioma, malignant-glioma, malignant-neoplasms, malignant-paraganglionic-neoplasm, mixed-gliomas, neoplasm-recurrence-local, neoplasms, oligodendroglioma, pilocytic-astrocytoma, supratentorial-neoplasms, tumor-progression.
Among the many pathways, these few ones have gauged particular interests from scientists studying Mixed Oligodendroglioma-astrocytoma, and have been seen in publications frequently: Angiogenesis, Autocrine Signaling, Cell Adhesion, Cell Cycle, Cell Cycle Arrest, Cell Differentiation, Cell Growth, Cell Migration, Cell Motility, Cell Proliferation, Dna Repair, Hypersensitivity, Interphase, Localization, Methylation, Mismatch Repair, Oncogenesis, Pathogenesis, Secretion, Sensitization
Quite a number of genes have been found to play important roles in Mixed Oligodendroglioma-astrocytoma, such as APTX, CDK4, CDKN2A, EGFR, GFAP, IDH1, IDH2, MGMT, MID1, PGR, POMT1, PTEN, SLC17A5, TEAD1, TMEM37, TP53, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.